NasdaqGS - Delayed Quote USD
Lyell Immunopharma, Inc. (LYEL)
0.4670
-0.0110
(-2.30%)
At close: 4:00:01 PM EDT
0.4670
0.00
(0.00%)
After hours: 4:32:09 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-162,394
-162,394
-163,694
-169,555
-126,249
Investing Cash Flow
122,424
122,424
184,048
-11,540
-121,573
Financing Cash Flow
1,326
1,326
1,743
10,635
401,244
End Cash Position
107,287
107,287
145,931
123,834
294,294
Capital Expenditure
-464
-464
-2,686
-24,276
-65,504
Issuance of Capital Stock
--
--
--
--
391,802
Free Cash Flow
-162,858
-162,858
-166,380
-193,831
-191,753
12/31/2021 - 6/17/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IKNA Ikena Oncology, Inc.
1.2100
0.00%
TYRA Tyra Biosciences, Inc.
10.09
+0.70%
IPSC Century Therapeutics, Inc.
0.5302
-1.81%
PMVP PMV Pharmaceuticals, Inc.
1.0800
+0.93%
PCSA Processa Pharmaceuticals, Inc.
0.2389
-0.13%
ALEC Alector, Inc.
1.1800
+1.72%
CRGX CARGO Therapeutics, Inc.
4.5250
-0.55%
SLRN Acelyrin, Inc.
2.1700
-3.56%
APGE Apogee Therapeutics, Inc.
37.05
+1.42%
ITOS iTeos Therapeutics, Inc.
7.46
+4.34%